Description
Class
Anthracyclines
MOA
Intercalation inhibits nucleotide replication and the action of DNA and RNA polymerases. The interaction of doxorubicin with topoisomerase II to form DNA-cleavable complexes appears to be an important mechanism of doxorubicin hydrochloride cytocidal activity.
Indications
- Adjuvant breast cancer
- Acute lymphoblastic leukemia
- Acute myeloblastic leukemia
- Hodgkin lymphoma
- Non-Hodgkin lymphoma (NHL)
- Metastatic breast cancer
- Metastatic Wilms’ tumor
- Metastatic neuroblastoma
- Metastatic bone sarcoma
- Metastatic ovarian carcinoma
- Metastatic transitional cell bladder carcinoma
- Metastatic thyroid carcinoma
- Metastatic gastric carcinoma
- Metastatic bronchogenic carcinoma
- Metastatic soft tissue sarcoma
- Pack Size
- 1’s
- Storage
- 2-8 °C
- Available Strength
- 10mg/5ml Injection
50mg/25ml Injection
